Latest News and Press Releases

PHOENIX, Dec. 04, 2015 (GLOBE NEWSWIRE) -- Insys Therapeutics, Inc. (Nasdaq:INSY) (“Insys” or “the Company”) today issued the following response to a recent report containing accusations centered...

PHOENIX, Ariz., Dec. 02, 2015 (GLOBE NEWSWIRE) -- Insys Therapeutics, Inc. (“Insys”) (NASDAQ:INSY) today announced the presenting speakers for its Investor Day to be held on Thursday, December 3,...

PHOENIX, Nov. 24, 2015 (GLOBE NEWSWIRE) -- Insys Therapeutics, Inc. (“Insys” or “the Company”) (NASDAQ:INSY) today announced that the Company will hold its Investor Day from 8:30 a.m. to 11:30...

PHOENIX, Nov. 23, 2015 (GLOBE NEWSWIRE) -- Insys Therapeutics, Inc. (“Insys” or “the Company”) (NASDAQ:INSY) today announced that Dan Brennan, Chief Operating Officer, and Darryl Baker, Chief...

PHOENIX, Nov. 23, 2015 (GLOBE NEWSWIRE) -- Insys Therapeutics, Inc. (“Insys” or “the Company”) (NASDAQ:INSY) today issued the following statement: INTRODUCTION Insys is committed to developing...

PHOENIX, Nov. 12, 2015 (GLOBE NEWSWIRE) -- Insys Therapeutics, Inc. (“Insys” or “the Company”) (NASDAQ:INSY) today announced that Darryl Baker, Chief Financial Officer, will present at the...

PHOENIX, Nov. 05, 2015 (GLOBE NEWSWIRE) -- Insys Therapeutics, Inc. (Nasdaq:INSY) (“Insys” or “the Company”) today announced that its Board of Directors has approved the repurchase of up to $50...

Michael Babich Departs as Insys President and CEO Dr. John N. Kapoor Appointed President and CEO Daniel Brennan Appointed Executive Vice President and Chief Operating Officer PHOENIX, Nov. 05,...

Announces Senior Management Changes and Appointments Announces Stock Repurchase up to $50 Million PHOENIX, Nov. 05, 2015 (GLOBE NEWSWIRE) -- Insys Therapeutics, Inc. (NASDAQ:INSY) ("Insys" or...

PHOENIX, AZ--(Marketwired - Oct 29, 2015) - Insys Therapeutics, Inc. (NASDAQ: INSY) ("Insys" or "the Company") today announced that the U.S. Food and Drug Administration ("FDA") has granted Fast...